NCT02936388View on ClinicalTrials.gov

Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis

PHASE2CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Uveal Melanoma

Interventions

PROCEDURE

SIRT

catheter-based application of radioactive microspheres into the hepatic artery

PROCEDURE

DSM-TACE

catheter-based application of chemotherapy and degradable starch microspheres into the hepatic artery

Trial Locations (1)

12200

Charité - University Medicine Berlin, Dept. of Haematology, Medical Oncology and Tumor Immunology, Campus Benjamin Franklin, Berlin

All Listed Sponsors

lead

Charite University, Berlin, Germany

OTHER

NCT02936388 - Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis | Biotech Hunter | Biotech Hunter